Medline Inc.
L10
| 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/28/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.79B | 7.12B | 6.89B | 6.77B | 6.78B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.79B | 7.12B | 6.89B | 6.77B | 6.78B |
| Cost of Revenue | 5.87B | 5.24B | 4.98B | 4.90B | 4.93B |
| Gross Profit | 1.91B | 1.88B | 1.91B | 1.86B | 1.85B |
| SG&A Expenses | 1.27B | 1.12B | 1.09B | 1.09B | 1.16B |
| Depreciation & Amortization | 176.00M | 177.00M | 176.00M | 175.50M | 177.00M |
| Other Operating Expenses | 30.00M | 8.00M | 14.00M | 15.00M | 16.00M |
| Total Operating Expenses | 7.34B | 6.54B | 6.26B | 6.18B | 6.29B |
| Operating Income | 443.00M | 574.00M | 629.00M | 581.00M | 494.00M |
| Income Before Tax | 206.00M | 345.00M | 359.00M | 348.50M | 305.00M |
| Income Tax Expenses | 26.00M | 23.00M | 26.00M | 21.00M | 16.00M |
| Earnings from Continuing Operations | 180.00M | 322.00M | 333.00M | 327.50M | 289.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.00M | -- | -- | -- | -- |
| Net Income | 182.00M | 322.00M | 333.00M | 327.50M | 289.00M |
| EBIT | 443.00M | 574.00M | 629.00M | 581.00M | 494.00M |
| EBITDA | 704.00M | 827.00M | 877.50M | 829.50M | 747.00M |
| EPS Basic | 0.22 | 0.02 | 0.02 | 0.02 | 0.02 |
| Normalized Basic EPS | 0.21 | 0.01 | 0.01 | -- | 0.01 |
| EPS Diluted | 0.22 | 0.02 | 0.02 | 0.02 | 0.02 |
| Normalized Diluted EPS | 0.21 | 0.01 | 0.01 | -- | 0.01 |
| Average Basic Shares Outstanding | 812.00M | 17.48B | 17.50B | -- | 17.47B |
| Average Diluted Shares Outstanding | 812.00M | 17.48B | 17.50B | 17.47B | 17.47B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 52.75% | 36.96% | 45.50% | 46.26% | 470.24% |